Duszkiewicz, R.; Strzelczyk, J.; Chełmecka, E.; Strzelczyk, J.K.
Serum Concentrations of IGF-1R, ERK2, and EGFR and Their Clinical Significance in Patients with Neuroendocrine Tumors. Appl. Sci. 2024, 14, 6998.
https://doi.org/10.3390/app14166998
AMA Style
Duszkiewicz R, Strzelczyk J, Chełmecka E, Strzelczyk JK.
Serum Concentrations of IGF-1R, ERK2, and EGFR and Their Clinical Significance in Patients with Neuroendocrine Tumors. Applied Sciences. 2024; 14(16):6998.
https://doi.org/10.3390/app14166998
Chicago/Turabian Style
Duszkiewicz, Roksana, Janusz Strzelczyk, Elżbieta Chełmecka, and Joanna Katarzyna Strzelczyk.
2024. "Serum Concentrations of IGF-1R, ERK2, and EGFR and Their Clinical Significance in Patients with Neuroendocrine Tumors" Applied Sciences 14, no. 16: 6998.
https://doi.org/10.3390/app14166998
APA Style
Duszkiewicz, R., Strzelczyk, J., Chełmecka, E., & Strzelczyk, J. K.
(2024). Serum Concentrations of IGF-1R, ERK2, and EGFR and Their Clinical Significance in Patients with Neuroendocrine Tumors. Applied Sciences, 14(16), 6998.
https://doi.org/10.3390/app14166998